|
|
News Breaks | | | | February 9, 2012 | | 08:27 EDT |  | UTHR | United Therapeutics inhaler devices may be recalled, says RBC Capital
After public reports submitted to the FDA indicated that 13 of United Therapeutics' Tyvaso inhalers have emitted smoke, sparkled, sizzled, or caught fire, RBC Capital thinks that the FDA could issue a warning letter about the matter or recall the product. The firm maintains a $45 target and Sector Perform rating on the stock. | |
|
News For UTHR From The Last 14 Days Check below for free stories on UTHR the last two weeks. |
|
|
| May 15, 2013 | | 12:37 EDT |  | UTHR | United Therapeutics downgraded to Hold from Buy at Standpoint Research
 Subscribe for More Information | |
|
|
|
|
|
|
